<DOC>
	<DOCNO>NCT01384656</DOCNO>
	<brief_summary>Patients undergoing multivessel off-pump coronary bypass surgery ( OPCAB ) inevitably experience cumulative ischemia-reperfusion injury myocardium . Glucose-insulin-potassium ( GIK ) potentially useful adjunct myocardial protection . This study design evaluate effect GIK infusion myocardium patient undergoing OPCAB . Patients undergo OPCAB acute coronary syndrome randomly assign GIK Control group . The trial double-blind conduct single center .</brief_summary>
	<brief_title>Effect Glucose-insulin-potassium Solution Myocardial Protection During Off-pump Coronary Bypass Surgery Patients With Acute Coronary Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>Patients undergo isolated OPCAB . Age : 20~75 . Emergency operation . Patients MR ≥ 2 . Patients IDDM . Patients random sugar ≥ 250 mg/dL . Patients serum creatinine ≥ 2.0 mg/dL . Patients acute myocardial infarction within 1 week surgery</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
</DOC>